The Scientist Who Says the Modern World Is Making Us Sick—And She’s One of the Sick
The day I was born, my mother developed an allergy to the modern world. That’s the simplest way I can explain what happened to her. Nearly everything could set off a reaction: newly laid carpet, plug-in air fresheners, the faint off-gassing from plastic containers, diesel fumes from passing trucks. Perfumes were by far the worst. On top of that, debilitating food allergies followed soon after. The constant sound of her sniffling was the background score of my entire childhood. Some days, she couldn’t even drag herself out of bed. I’d creep to the door of her dark, closed room and peek in, seeing her face twisted tight with unrelenting discomfort.
Her joints ached constantly, her head spun so badly she could barely stand. Most doctors brushed it off: she was just depressed, or anxious, they said. Her response was always sharp: “You’d be anxious too if you couldn’t even lick a stamp, couldn’t drive your own daughter to the park in your car.” She saw allergist after allergist, got nowhere, until she turned to holistic health practitioners, who gave her a name for what she had: multiple chemical sensitivity.
For as long as people have reported that man-made chemicals in everyday environments cause migraines, asthma, exhaustion, and crippling mood swings, mainstream medicine has largely written them off. The American Medical Association, World Health Organization, and American Academy of Asthma, Allergy & Immunology do not recognize chemical sensitivity as a valid medical diagnosis. When they do address it, they dismiss it as a psychosomatic condition, something that only affects neurotic, health-obsessed people. These leading medical bodies ask: why would people react to trace amounts of thousands of different chemicals? And why can no treatment ever make them fully well?
This is no trivial complaint. Roughly one in four American adults report some form of chemical sensitivity; it sits alongside chronic pain and fibromyalgia as a condition that is visibly debilitating for patients, yet stubbornly unrecognized by mainstream medicine and untreatable by its standards. My mom tried everything to get better: elimination diets, antihistamines, lymphatic drainage massage, antidepressants, acupuncture, red light therapy, infrared saunas, heavy metal detoxes. Sometimes her symptoms softened a little, but she never recovered. Her illness controlled every part of our lives, dictating what groceries we could buy, what meals we ate, what places we could even visit. I grew up convinced there had to be an explanation for what was happening to her—and to millions like her. It didn’t take me long to find the woman who might hold that answer: a soft-spoken, unassuming scientist named Claudia Miller, whose work upends everything mainstream medicine thinks about this misunderstood condition.
A Lifetime of Fighting for Recognition
On a warm, sun-dappled afternoon in San Antonio, Texas, Miller and her warm, easygoing husband Bob walked with me through the San Antonio Botanical Garden. A monarch butterfly darted past our shoulders. “I’ve noticed so many fewer butterflies, so many fewer birds even in just the last few years,” Miller observed. Her voice is raspy and so quiet that my recorder often couldn’t pick it up; most people spend half their conversation leaning in to hear her, asking her to repeat herself. At 78, she usually uses a cane, but Bob pulled a walker from the car to let her cover more ground. Her silver hair is pulled back into a low side ponytail, held in place with a simple fabric scrunchie.
With her wide, thin-rimmed glasses, Miller blends into the scenery—but she is one of the most prominent voices in her niche field. Now a professor emerita at the University of Texas Health Science Center at San Antonio, she has held multiple federal appointments, chaired research meetings for the National Institutes of Health, testified before Congress, consulted for the Environmental Protection Agency, published dozens of peer-reviewed papers, and advised the governments of Canada, Germany, Japan, and Sweden on chemical intolerance. For her tireless work advocating for overlooked, dismissed patients, one patient advocate I interviewed called her “Saint Claudia.” Kristina Baehr, an attorney who represents victims of toxic exposure, told me: “To have an expert like Dr. Miller tell you ‘you’re not crazy, this is real’ is life-giving for these people. She validates their experience with hard science, not just empathy.”
Miller sums up her core argument simply: Over the last century, the United States has undergone a hidden chemical revolution. “Fossil fuels—coal, oil, natural gas—their byproducts, and all the synthetic chemicals we derive from them, are almost entirely new to the human body since World War II,” she explains. “Plasticizers, forever chemicals, you name it: none of these are chemicals that humans evolved to be exposed to.” They are everywhere, in every home, office, park, and school—and Miller is convinced they are making millions of people chronically ill.
In 1997, Miller put forward the career-defining theory that explains how this happens. It has the technical name toxicant-induced loss of tolerance, shortened to the easy acronym TILT. You can develop this loss of tolerance after one single massive toxic exposure, Miller explains, or after a lifetime of repeated small exposures. Either way, a biological switch gets flipped: suddenly, people react to even tiny amounts of everyday substances—cigarette smoke, antibiotics, natural gas from a kitchen stove—that never bothered them before. These people are, as Miller puts it, “TILT-ed.” The process works a lot like developing an allergy: the body labels an otherwise harmless substance as dangerous, and mounts an immune response every time it encounters it.
Two years later, Miller and her colleagues created the Quick Environmental Exposure and Sensitivity Inventory, or QEESI (pronounced “queasy”), a simple survey to help doctors and researchers identify people with chemical intolerance. I’ve seen the QEESI cited in research papers from 18 countries, but to this day, most practicing physicians have never heard of it. “It’s incredibly frustrating trying to get these ideas accepted by the mainstream,” Miller says. The biggest barrier right now: even if TILT accurately describes how people become chemically intolerant, scientists still don’t know exactly what biological changes happen in the sensitized body, why so many different symptoms pop up, or why one person exposed to the same chemicals gets sick and another stays fine. But Miller says she is closer than ever to solving that mystery.
As we walked through the botanical garden, we stopped at the orchid greenhouse, where thick, sticky heat wrapped around us. Hundreds of orchids in every shape and color lined the displays, including one with spindly chartreuse petals I couldn’t identify with my plant ID app. That’s what chemical intolerance is like, Miller says: it defies easy identification and diagnosis. “The world becomes a torture chamber for you, and then nobody believes you,” she says. “That’s the worst part.” After getting sick, some people become hermits, cutting off friends and family to move to remote areas to avoid exposure. Others can never get their symptoms under control, and spiral. My mom knew a woman who moved to a rural trailer to escape her triggers. Eventually even that wasn’t enough, and she died by suicide.
A Personal Proof of What’s Real
I’ve never doubted my mom’s illness—not after the worst thing I ever did to another person, when I was 10 years old. We were at a disastrous family reunion that week; we fought nonstop, everyone cried, even the photographer ruined the family portrait by exposing the film. We would have erased the whole week from our memories if we could. During the trip, my aunt gave me a set of scented lip balms. My mom gave my aunt a tight smile, but pulled me aside as soon as we were alone and told me to throw them away.
Instead, I hid them. And after another fight with my parents, I used them as a weapon. I snuck into my mom’s room, pulled back her pillowcase, and smeared the scented balm directly onto her pillow. That night, when she tried to sleep, she woke up over and over, getting sicker by the minute, her head throbbing so badly she could barely breathe. Eventually, her nose led her to what I’d done. She found the sticky, scented smudges on her pillow. The next day, my dad told me how she’d sobbed and cried out: “Why would she do this to me?”
That memory is still a source of crippling guilt for me. But it was also the proof I needed: my mom’s illness wasn’t in her head. It was real.
Later, I sat in Miller’s condo, across the street from the UT Health Science Center, with Miller and two of her research collaborators. Her dining table was lined with common household items: a votive candle, a box of matches, body lotion, scented dish soap. Next to them sat bulky monitors that looked like something out of Ghostbusters. These are particulate monitors that measure chemical exposure down to parts per billion. They have to be hypersensitive, because even the tiny molecules released by everyday scented products can trigger reactions in chemically intolerant people—similar to how someone with a severe peanut allergy can react to a peanut opened on the other side of a plane. One collaborator struck a single match in front of the sensor. The reading on the screen jumped instantly from 0 to nearly 500,000 parts per billion. You can’t always smell that level of pollution, but it’s there, and it can make people sick.
Last year, Miller’s team published a study of nearly 40 chemically intolerant patients, where they visited patients’ homes, measured indoor pollution from products like these, plus irritants like dust and mold, and ran blood tests to check for allergies. Then they recommended simple changes: throwing out scented candles, moving gasoline cans from an attached garage to a separate storage shed, and gave patients unscented natural cleaning products. They retested the homes multiple times over a year. As indoor chemical pollution dropped, patients’ symptoms improved significantly.
For years, this kind of result convinced Miller that her patients’ illness was real—but she still couldn’t explain the biological mechanism behind it. Then she learned about mast cells.
Mast cells are a type of white blood cell found in nearly every tissue of the body: skin, lungs, digestive tract, everywhere. When they detect a threat, they release hundreds of inflammatory chemicals, including histamine, that trigger symptoms like hives, swelling, or anaphylaxis during an allergic reaction. If mast cells become overactive, they release too many inflammatory chemicals at the wrong time, leading to constant symptoms like flushing, dizziness, wheezing, and exhaustion. That condition is called mast cell activation syndrome, or MCAS.
When Miller read a book on MCAS by Lawrence Afrin, a New York-based hematologist and mast cell researcher, she immediately noticed that MCAS symptoms lined up almost perfectly with chemical intolerance. She called Afrin, and they discovered that many of his MCAS patients were also sensitive to fragrances and medications, just like Miller’s TILT patients. In 2021, Miller published what she calls her second eureka moment: a paper co-authored with Afrin and other researchers that lays out a clear potential link between TILT and MCAS. The team surveyed MCAS patients and found that people who scored high on MCAS assessments also scored high on the QEESI for chemical intolerance. The two conditions had nearly identical symptom patterns.
Could Miller’s patients have had MCAS this whole time? MCAS is still tricky to diagnose and treat, but it was a breakthrough: an explanation for the scientific community, an answer for patients, and a personal answer for Miller too. Because there’s a part of the story Miller has only recently been willing to share: the leading researcher of chemical intolerance has it herself.
A Quest Decades in the Making
Miller struggles to pinpoint exact dates from her past, she says—blame age, or the brain fog that comes with her illness. But over hours of conversation and dozens of emails, her story comes into focus. Born in Milwaukee, an only child to a patent attorney and a teacher, she loved science from a young age. She earned a bachelor’s in molecular biology from University of Wisconsin-Madison, a master’s in environmental health from UC Berkeley, then worked for years in Chicago as an industrial hygienist for OSHA and the United Steelworkers, touring steel mills, coke ovens, and smelters to check worker safety. It was there that she first started seeing patterns of the illness that would define her career.
Once, she was called in to meet women who worked soldering in an electronics plant. They had what management called an outbreak of “mass psychogenic illness.” A manager brought one of the sick women into his office, started soldering right in front of us, and the woman started having symptoms immediately. Management said that proved it was all in her head—why wasn’t he or Miller affected? But Miller suspected something else was going on, even if she couldn’t name it yet.
She met Bob, also an industrial hygienist, through OSHA. In 1977, newly married, they moved into an old home in a green, quiet neighborhood of Lake Forest, Illinois. They loved gardening, watching foxes visit the nearby pond. But the house had wasps and spiders, so they hired an exterminator to spray an EPA-approved pesticide on the floorboards and eaves. “That changed our entire lives,” Miller says.
Immediately, Miller was hit with crippling fatigue and brain fog so bad she could barely think straight. Bob felt fine, so they still went on their planned honeymoon to New Orleans, leaving their two-month-old Burmese kitten with Miller’s parents. Mid-trip, they got a call: their kitten was lethargic, and the next day, it died. Miller was convinced the pesticide had poisoned both her and the kitten, but she couldn’t find any doctor who would help her get better.
Eventually, she was referred to Theron Randolph, an allergist who had broken with mainstream medicine after decades of working with chemically sensitive patients. Mainstream allergists at the time held to the idea that “the dose makes the poison”: any substance can be harmful in large enough amounts, but trace chemicals can’t make you sick. Randolph disagreed: he argued that small repeated exposures build up a toxic burden in the body over time, and that even trace amounts can trigger illness. For that work, he was fired from his faculty position at Northwestern University Medical School, and became a lightning rod for criticism from peers who said he relied too much on patient testimony and unorthodox testing.
Desperate to get her health back, Miller checked herself into one of Randolph’s “environmental medical units” for three weeks. These units were outfitted with non-outgassing materials: ceramic floors and walls, metal furniture, filtered fresh air, locked entrances to keep outside chemicals out. No disinfectants or fragrances were allowed. The program started with a week-long fast. By her third day, Miller felt better than she had in months: “My head was clear, I could remember things again.”
That experience hooked Miller’s scientific curiosity. She flooded Randolph with questions every day, eventually joined his staff meetings, and presented her work on mass psychogenic illness at an NIH meeting in 1979. She argued that these outbreaks weren’t mass hysteria—they had a clear chemical cause. After she finished, attendees lined up at the microphone to challenge her, a preview of the pushback she would face for the rest of her career.
Randolph told her she needed to go to medical school if she wanted to change the minds of the mainstream establishment: “You have to learn everything they know,” he told her. But there was a problem: her stay at Randolph’s unit only improved her health temporarily. When she got back to her Chicago home, she got sick again. So she and Bob moved to Texas, where she enrolled in medical school at UT. “If I’d told them about my own chemical intolerance, I never would have been accepted,” she told me. She pretended she was just interested in allergy and immunology, while struggling with her symptoms in private. If a patient came in reeking of cigarette smoke, she’d be knocked out with dizziness for hours. Most foods made her sick. “Her main go-to meal was chocolate,” Bob jokes. Sometimes she would fast before exams just to get a little of the clear-headedness she felt at Randolph’s unit.
After getting her degree, Miller started her work in earnest. She was appointed to the National Advisory Committee on Occupational Safety and Health, where she met Nicholas Ashford, an MIT environmental policy professor who became her long-time collaborator. They published a landmark report on chemical sensitivity for New Jersey in 1989, followed by their seminal book Chemical Exposure: Low Levels and High Stakes in 1991.
Miller kept her own illness a secret for decades, at Ashford’s advice: “You don’t want to distract from the good science you’re doing,” he told her. She studied Gulf War veterans who came home with chemical sensitivity after exposure to chemical weapons, worked with EPA staff who got sick after their office installed new latex-backed carpet, testified to the FDA about patients with breast implants who developed sudden chemical intolerances. She corresponded with Bernie Sanders for years trying to get the government to fund Randolph-style environmental medical units. All the while, she suffered in silence. It wasn’t until 40 years after her pesticide exposure, when she connected TILT to MCAS, that she felt confident enough to go public with her own story.
When I visited her condo, she showed me two of her art pieces, both depicting Don Quixote—the iconic character who tilts at windmills he mistakes for giants. The first shows Quixote and his horse beaten on the ground after attacking a windmill. “He’s tilting at windmills,” she says. “That’s what I feel like I’m doing.” I got the wordplay, of course: her work is all about TILT.
Miller is single-minded in her mission, and unafraid to make enemies. She talks often about Elon Musk: her research found that people with high chemical intolerance scores are 5.7 times more likely to have a child with autism, and 2.1 times more likely to have a child with ADHD (full disclosure: I am a child of a chemically intolerant mother, and I have ADHD). Miller gave me a copy of Maye Musk’s memoir, which mentions that Maye painted her husband’s plane while pregnant with Elon. Miller speculates that exposure may have contributed to Elon Musk’s autism spectrum diagnosis, and says that a high-profile story about this link “could crack open the whole field.” She has even wondered if Musk might fund the environmental medical units she’s spent decades pushing for. Out of the blue, she sent me an email that read, in full: “When I was an eight-year-old girl living in Milwaukee, I never imagined I would become a doctor and diagnose the richest man in the world.”
Another core fight for Miller is terminology. She hates the name “multiple chemical sensitivity,” calling it stigmatizing and imprecise. It doesn’t account for people who become TILT-ed after mold
